If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Roberto Luksch is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 27 Similar Profiles
Neuroblastoma Medicine & Life Sciences
Ewing's Sarcoma Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Sarcoma Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

  • 3507 Citations
  • 35 h-Index
  • 164 Article
  • 1 Chapter

Exosomal microRNAs from longitudinal liquid biopsies for the prediction of response to induction chemotherapy in high-risk neuroblastoma patients: A proof of concept SIOPEN study

Morini, M., Cangelosi, D., Segalerba, D., Marimpietri, D., Raggi, F., Castellano, A., Fruci, D., De Mora, J. F., Cañete, A., Yáñez, Y., Viprey, V., Corrias, M. V., Carlini, B., Pezzolo, A., Schleiermacher, G., Mazzocco, K., Ladenstein, R., Sementa, A. R., Conte, M., Garaventa, A. & 5 others, Burchill, S., Luksch, R., Bosco, M. C., Eva, A. & Varesio, L., Oct 2019, In : Cancers. 11, 10, 1476.

Research output: Contribution to journalArticle

Open Access
Induction Chemotherapy
MicroRNAs
Neuroblastoma
Biopsy
Exosomes
Hepatic Veno-Occlusive Disease
Hematopoietic Stem Cell Transplantation
Stem Cell Transplantation
Hematology
Retrospective Studies

Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis

Corrias, M. V., Parodi, S., Tchirkov, A., Lammens, T., Vicha, A., Pasqualini, C., Träger, C., Yáñez, Y., Dallorso, S., Varesio, L., Luksch, R., Laureys, G., Valteau-Couanet, D., Canete, A., Pöetschger, U., Ladenstein, R. & Burchill, S. A., 2018, In : Pediatric Blood and Cancer. 65, 7

Research output: Contribution to journalArticle

Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis

Corrias, M. V., Parodi, S., Tchirkov, A., Lammens, T., Vicha, A., Pasqualini, C., Träger, C., Yáñez, Y., Dallorso, S., Varesio, L., Luksch, R., Laureys, G., Valteau-Couanet, D., Canete, A., Pöetschger, U., Ladenstein, R. & Burchill, S. A., Jul 2018, In : Pediatric Blood and Cancer. 65, 7, p. e27052

Research output: Contribution to journalArticle

Homeobox Genes
Neuroblastoma
Disease-Free Survival
Tyrosine 3-Monooxygenase
Messenger RNA

Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients

Camisaschi, C., Renne, S. L., Beretta, V., Rini, F., Spagnuolo, R. D., Tuccitto, A., Podda, M. G., Parmiani, G., Rivoltini, L., Collini, P., Castelli, C. & Luksch, R., Oct 16 2018, In : BMC Cancer. 18, 1, p. 983

Research output: Contribution to journalArticle

Neoplasm Antigens
Neuroblastoma
Peptides
Cancer Vaccines
T-Lymphocytes